KFP
EBS icon

KB Financial Partners’s Emergent Biosolutions EBS Stock Holding History

KB Financial Partners’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-95
Closed -$6K – 283
2021
Q2 		$6K Sell
95
-26
-21% -$1.67K ﹤0.01% 455
2021
Q1 		$11K Buy
+121
New +$12.4K ﹤0.01% 431

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

KB Financial Partners's EBS Position: Q3 2021 in Review

KB Financial Partners sold out of Emergent Biosolutions (EBS) in Q3 2021, closing a stake of 95 shares — an estimated $6K sold.

KB Financial Partners first reported a position in EBS in Q1 2021 and held it in 2 quarters. The position peaked at $11K in Q1 2021. 277 funds tracked by Wall St. Rank hold EBS as of Q3 2021.

  • KB Financial Partners reported no remaining Emergent Biosolutions position as of Q3 2021 after selling out during the quarter.
  • KB Financial Partners sold 95 Emergent Biosolutions shares in Q3 2021, an estimated $6K.
  • KB Financial Partners first reported a position in Emergent Biosolutions in Q1 2021 and held it in 2 quarters.
  • KB Financial Partners's Emergent Biosolutions position peaked at $11K in Q1 2021.
  • 277 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2021.

Based on KB Financial Partners's 13F filing for Q3 2021, filed 16 Nov 2021.